Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomatitis × brilacidin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Stomatitis 1 Mucositis 1 Head and Neck Neoplasms 1

Interventions

Low-Level Light Therapy 11 Fibroblast Growth Factor 7 7 Cisplatin 5 Standard of Care 4 Propolis 4 Mouthwashes 4 Cryotherapy 4 Water 3 Saline Solution 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Injections 3 Benzydamine 3 avasopasem manganese 2 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Vitamin E 2 Vitamin B 12 2 Sodium Chloride 2 RRx-001 2 Lidocaine 2 Honey 2 Glutamine 2 Gentamicins 2 Diphenhydramine 2 Control Groups 2 Chlorhexidine 2 Ascorbic Acid 2 Acetylcysteine 2 whole grape extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed

61 enrolled 12 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡